Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07634640 · ClinicalTrials.gov registry record · Early Phase 1
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
A Early Phase 1 study, sponsored by University of Florida.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 70
- Enrollment target
NCT07634640: Recruiting Early Phase 1 study, sponsored by University of Florida.
NCT07634640 is a Early Phase 1 study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 70 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (32% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07634640, a Early Phase 1 study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Interventions
- DRUG Ferumoxytol infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2027-05-31 |
| Phase | Early Phase 1 |
What NCT07634640 shows while recruiting
NCT07634640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (32% higher).
The record links to 0 conditions, and to 1 intervention - of which Ferumoxytol infusion is the first listed.
NCT07634640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07634640 about?
NCT07634640 is a clinical study titled "Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction". Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
What is the current status of trial NCT07634640?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 70 participants. The study started on 2023-11-03. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT07634640?
The interventions under investigation include: Ferumoxytol infusion (DRUG).
Who is sponsoring clinical trial NCT07634640?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07634640's enrollment target sits among peer trials
70 339th of 2000 higher than 1,647 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI